MedTrace Logo

Stem Cell Therapy in Non-IschEmic Non-treatable Dilated CardiomyopathiEs II: a Pilot Study

NCT03797092 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-01-19

No results posted yet for this study

Summary

The overall aim of the project is to test the feasibility and safety of allogeneic adipose-derived stromal cells (CSCC\_ASC) investigational medicinal product, to improve myocardial function in patients with non-ischemic dilated cardiomyopathies (NIDCM) and heart failure.

Conditions

  • Non-ischemic Dilated Cardiomyopathy

Interventions

BIOLOGICAL

Allogeneic adipose-derived stromal cells (CSCC_ASC)

Active group

OTHER

Control group

No treatment

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    collaborator OTHER

  • JKastrup

    lead OTHER

Principal Investigators

  • Bojan Vrtovec, MD, PhD · Dep. of Cardiology, Uni. Medical Center Ljubljana, Slovenia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-07-01
Completion
2021-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03797092 on ClinicalTrials.gov